POSTER SESSION II
Monday, March 26, 2007   —  1:00 PM - 4:30 PM
Convention Center, Exhibit Hall B - 1


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
11 Metaplastic Tumor of the Breast with Pure Sarcomatous Phenotype Associated with Ductal Carcinoma In Situ: Analysis and Characterization of Eight Cases (97)
FI Boulos, JR Stumph, NM Granja, ME Sanders, JF Simpson, DL Page - Vanderbilt University Medical Center, Nashville, TN
Add
12 Primary Angiosarcoma of the Breast: Clinicopathologic Analysis of 45 Cases (175)
AF Nascimento, CP Raut, CDM Fletcher - Brigham and Women’s Hospital & Harvard Medical School, Boston, MA
Add
13 Malignant Spindle Cell Tumors of the Breast Demonstrate Overlapping Immunoprofiles for Cytokeratin and Myoepithelial Markers (209)
SJ Shin, PP Rosen - Weill Medical College of Cornell University, New York, NY
Add
14 Genomic Profiling of Heterologous Metaplastic Breast Carcinoma (MBC) Show Clonal Similarities between Different Lesion Types but Also Distinct Differences Which Might Account for Their Morphological Features (186)
DG Powe, M Ademola, MBK Lambros, T Abdel-Fatah, IO Ellis, JS Reis-Filoh - Nottingham University, Nottingham, United Kingdom; Institute of Cancer Research, London, United Kingdom
Add
15 Expression of the Cell Adhesion Molecule Laminin-5 Correlates with p63 Expression in Metaplastic Carcinoma of the Breast (207)
CL Schiller, WR Wiseman, SM Sitterding, C Luan, WG Watkin, EL Wiley, MZ Gilcrease, LK Diaz - Feinberg School of Medicine Northwestern University, Chicago, IL; Evanston Northwestern Healthcare, Evanston, IL; University of Texas MD Anderson Cancer Center, Houston, TX
Add
16 Aberrant β-Catenin Expression Is Associated with Morphology and Prognosis in Metaplastic Mammary Carcinomas (139)
MJ Hayes, A Witkiewicz, CG Kleer - University of Michigan Medical Center, Ann Arbor, MI; Thomas Jefferson University, Philadelphia, PA
Add
17 Adenoid Cystic Carcinoma of the Breast: Frequent Margin Involvement after Primary Surgery (161)
A Lytwyn, N Hodgson, D Hileeto, S Bacopoulus, D Browing, N Howatt, LJ Elavathil - McMaster University, Hamilton, ON, Canada
Add
18 Stromal Expression of CD34 and 14.3.3σ May Differentiate Phyllodes Tumor from Fibroadenoma (155)
DF Klink, MO Idowu, MM Grimes, JL Ware - VCU Medical Center, Richmond, VA
Add
19 Mitotic Index Evaluated with Phosphohistone H3 as Only Predictor of Outcome on Surgical Excision in Challenging Fibroepithelial Lesions (217)
MC Uzquiano, E Resetkova, E Arribas, A Sahin - MD Anderson, Houston, TX
Add
20 Loss of Myoepithelium and Laminin at the Tumor-Stromal Interface in Circumscribed Solid Papillary Carcinoma of the Breast (176)
MM Nicolas, Y Wu, LP Middleton, MZ Gilcrease - M. D. Anderson Cancer Center, Houston, TX
Add
21 Immunohistochemical Phenotypes of Invasive Breast Carcinoma with Negative Axillary Lymph Nodes (84)
FI Aranda, G Peiró, E Adrover, J Seguí, M Niveiro, M Planelles, C Alenda - Hospital General de Alicante, Alicante, Spain
Add
22 FGFR1 Amplification in Breast Carcinomas: A Chromogenic In Situ Hybridization Analysis (116)
SE Elsheikh, A Green, MB Lambros, D Powe, IO Ellis, JS Reis-Filho - University of Nottingham, Nottingham, United Kingdom; Institute of Cancer Research, London, United Kingdom
Add
23 Global Histone Modifications in Breast Cancer and Their Prognostic Significance (114)
SE El-Sheikh, AR Green, EA Rakha, EC Paish, DM Heery, IO Ellis - Queen’s Medical Centre, University of Nottingham, Nottingham, United Kingdom; University of Nottingham, Nottingham, United Kingdom
Add
24 Estrogen Receptor Co-Activator (AIB1) Protein Expression by Automated Quantitative Analysis in a Breast Cancer Tissue Microarray and Association with Patient Outcome (137)
M Harigopal, J Heymann, RL Camp, DL Rimm - Yale Univ. School of Medicine, New Haven, CT
Add
25 Lymphangiogenesis and Angiogenesis in Breast Cancer: Correlation with Clinicopathologic Features and Axillary Lymph Node Metastases (164)
VFZ Marinho, K Metze, GFS Rocha, FSF Sanches, H Gobbi - Universidade Federal de Minas Gerais & UFMG, Belo Horizonte, Minas Gerais, Brazil; Universidade Estadual de Campinas & UNICAMP, Campinas, São Paulo, Brazil
Add
26 Intra- and Peritumoral Lymphatic Vessel Density in Breast Cancer: Correlation with Clinicopathologic Features and Prognostic Significance (81)
G Acs, X Xu, T Pasha, PJ Zhang - H. Lee Moffitt Cancer Center, Tampa, FL; University of Pennsylvania Medical Center, Philadelphia, PA
Add
27 Peritumoral Lymphatic Vascular Density as a Prognostic Marker in Invasive Breast Carcinoma (113)
YM El-Gohary, RS Saad, MJ Robinson, RJ Poppiti - Mount Sinai Medical Center, Miami Beach, FL
Add